Novartis’ Analytic Capabilities A Key Part Of WellPoint Health IT Pilot
Executive Summary
Although pharmaceutical industry participation may not be critical in terms of rolling out a comprehensive health information technology program, WellPoint sees clear advantages to bringing in drug manufacturers and is currently working with Novartis to help analyze a new program the insurer is developing